Are Options Traders Bullish on ADRO?
Let daily Option Order Flow show you where stock investors are Bullish and Bearish!!! Receive a FREE daily email of the Market Chameleon Order Flow Sentiment Newsletter.
Market Chameleon
Aduro Biotech Inc.

ADRO

6.20

-0.10

-1.6%

After Hours:

6.20

0.00

0.0%

Please Login or Register

Login|Register FREE

Please Login or Register

Login|Register FREE

Stock Price
Open: 6.25
Prev. Close: 6.30
Low/Hi: 6.00 - 6.40
52-Week: 5.10 - 11.55
Volumes
Equity: 1,044,603
90-Day Avg: 376,412
Option: 67
90-Day Avg: 160
Volatility
Todays Stock Vol: 61.1
20-Day (HV): 95.9
52-Week (HV): 69.4
30-Day IV: 104.7 -3.8
IV Pct Rank: 91% Elevated
Fundamental
Div. Yield:
Earnings: 1-Nov (Est.)
P/E Ratio:
Market Cap: 498.1 M
Short Int Pct: 0.0%
Pct Held By Inst.: 45.8%
Stock Info
Type: Common
Sector: Healthcare
Industry: Biotechnology

About ADRO

Aduro Biotech, Inc. is a clinical-stage immuno-oncology company focused on the development of technology platforms to stimulate an immune response against cancer. Aduros lead platform is based on proprietary strains of live-attenuated, double-deleted (LADD) Listeria monocytogenes that induce a potent innate immune response and have been engineered to express tumor-associated antigens to induce tumor-specific T cell-mediated immunity. Aduro has received Breakthrough Therapy designation from the FDA for its lead LADD regimen, CRS-207 in combination with GVAX Pancreas in pancreatic cancer. The company is evaluating the proprietary immuno-oncology combination in the ongoing Phase 2b ECLIPSE clinical trial and has additional ongoing clinical trials with its LADD platform in mesothelioma and glioblastoma. The company is also developing clinical candidates using cyclic dinucleotide (CDN) synthetic small molecule immune modulators that are designed to activate the intracellular STING receptor, a central mediator of the innate immune response.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ADRO is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
ITOT iShares Core S&P Total U.S. Stock Market ETF 16.1 B 1.61062E+10 3,418 3418 0.0% 0 86 K 85958
IWM iShares Russell 2000 ETF 47.3 B 4.72794E+10 2,002 2002 0.02% 0.0002 8.4 M 8449290
IWO iShares Russell 2000 Growth ETF 11.1 B 1.11387E+10 1,211 1211 0.04% 0.0004 4.1 M 4050410
IWV iShares Russell 3000 ETF 9.2 B 9.17944E+09 2,983 2983 0.0% 0 141 K 140826
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 2.0 B 2E+09 968 968 0.01% 8.02231E-05 161 K 161005
SBIO ALPS Medical Breakthroughs ETF 276.8 M 2.7675E+08 113 113 0.32% 0.0032 886 K 885600
UBIO Proshares UltraPro Nasdaq Biotechnology 35.3 M 3.52545E+07 196 196 0.01% 0.000120571 14 K 14156
URTY ProShares UltraPro Russell2000 159.0 M 1.59036E+08 2,011 2011 0.0% 2.74749E-05 15 K 15133
UWM ProShares Ultra Russell2000 260.7 M 2.607E+08 2,011 2011 0.01% 6.19498E-05 36 K 35916
BIB ProShares Ultra Nasdaq Biotechnology 377.2 M 3.7725E+08 202 202 0.02% 0.000211269 177 K 176740
EQWS Invesco Russell 2000 Equal Weight ETF 26.3 M 2.63E+07 1,969 1969 0.03% 0.00025 6 K 6406
FHLC Fidelity MSCI Health Care Index ETF 1.5 B 1.5E+09 349 349 0.01% 5.86192E-05 85 K 85056
IBB iShares Nasdaq Biotechnology Index Fund 9.4 B 9.4328E+09 191 191 0.06% 0.0006 5.7 M 5727300

Wait, Before You Leave...